| 1 |
Han X, Duan M, Hu L, et al. Plasmablastic lymphoma: review of 60 Chinese cases and prognosis analysis[J]. Medicine (Baltimore), 2017，96(9):e5981.
|
| 2 |
Castillo J, Pantanowitz L, Dezube BJ. HIV-associated plasmablastic lymphoma: lessons learned from 112 published cases[J]. Am J Hematol, 2008，83(10):804-809.
|
| 3 |
Delecluse HJ, Anagnostopoulos I, Dallenbach F, et al. Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection[J]. Blood, 1997，89(4):1413-1420.
|
| 4 |
Ott G, Rosenwald A, Campo E. Understanding MYC-driven aggressive B-cell lymphomas: pathogenesis and classification[J]. Blood, 2013，122(24):3884-3891.
|
| 5 |
Hadžisejdić I, Babarović E, Vranić L, et al. Unusual presentation of plasmablastic lymphoma involving ovarian mature cystic teratoma: a case report[J]. Diagn Pathol, 2017，12(1):83.
|
| 6 |
Keyvani H, Karbalaie NMH, Esghaei M, et al. Presence of human herpesvirus 8 (HHV-8) DNA sequences in patients with lymphoproliferative diseases and chronic blood disorders[J]. Microb Pathog, 2017，111:431-434.
|
| 7 |
Castillo JJ, Bibas M, Miranda RN. The biology and treatment of plasmablastic lymphoma[J]. Blood, 2015，125(15):2323-2330.
|
| 8 |
Morscio J, Dierickx D, Nijs J, et al. Clinicopathologic comparison of plasmablastic lymphoma in HIV-positive, immunocompetent, and posttransplant patients: single-center series of 25 cases and meta-analysis of 277 reported cases[J]. Am J Surg Pathol, 2014，38(7):875-886.
|
| 9 |
陈玉，刘艳辉，罗东兰，等. 人免疫缺陷病毒阴性的浆母细胞性淋巴瘤临床病理观察[J]．中华病理学杂志，2015，44(8):548-552.
|
| 10 |
Cao C, Liu T, Zhu H, et al. Bortezomib-contained chemotherapy and thalidomide combined with CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) play promising roles in plasmablastic lymphoma: a case report and literature review[J]. Clin Lymphoma Myeloma Leuk, 2014，14(5):e145-e150.
|
| 11 |
韩潇，胡立星，欧阳明祈，等. 八例HIV阴性的浆母细胞淋巴瘤患者临床特征及转归[J]. 中华血液学杂志，2017, 38(4):290-294.
|
| 12 |
冯娟，杨莉洁，陈协群，等. 浆母细胞淋巴瘤的诊治进展[J]．现代生物医学进展，2016，16(12):2359-2362.
|
| 13 |
邝丽芬，李娟，黄蓓晖，等. 含硼替佐米方案的诱导治疗序贯自体造血干细胞移植治疗初诊时合并髓外病变的多发性骨髓瘤的疗效分析[J]．临床血液学杂志，2016，29(1):24-28.
|
| 14 |
李芬，丁文双，左卓，等. 浆母细胞性淋巴瘤11例临床病理分析及文献复习[J]. 中华病理学杂志，2016, (1):37-42.
|
| 15 |
Satwani P, Jin Z, Martin PL, et al. Sequential myeloablative autologous stem cell transplantation and reduced intensity allogeneic hematopoietic cell transplantation is safe and feasible in children, adolescents and young adults with poor-risk refractory or recurrent Hodgkin and non-Hodgkin lymphoma[J]. Leukemia, 2015，29(2):448-455.
|
| 16 |
Hamadani M, Devine SM. Reduced-intensity conditioning allogeneic stem cell transplantation in HIV patients with hematologic malignancies: yes, we can[J]. Blood, 2009，114(12):2564-2566.
|
| 17 |
Nishi K, Mitani S, Hatanaka K, et al. Successful cord blood transplantation for an HIV-negative patient with refractory plasmablastic lymphoma[J]. Ann Hematol, 2017，96(6):1057-1058.
|
| 18 |
桂琳，何小慧，刘鹏，等. 九例人免疫缺陷病毒阴性的浆母细胞淋巴瘤临床特征及文献复习[J]．中华血液学杂志，2016，37(9):762-767.
|
| 19 |
杜建伟，孙星，李钢苹，等. 九例人免疫缺陷病毒阴性浆母细胞淋巴瘤患者临床特征分析[J]．中华血液学杂志，2016，37(12):1077-1080.
|